Loading organizations...
SilverArc Capital is an investment management firm specializing in actively traded funds within the healthcare sector, with a pronounced focus on biotechnology investments. The firm applies a deep industry understanding to navigate the complexities of this specialized market.
Founded in 2012 by Devesh Sharad Gandhi, SilverArc Capital emerged from his extensive background as a senior analyst at Sonar Capital. Gandhi's insight centered on the burgeoning opportunities and intricacies of the biotech landscape, recognizing the need for specialized investment management to capture value in this dynamic industry.
SilverArc Capital serves sophisticated investors, including hedge fund allocators and family offices, seeking dedicated exposure to the healthcare and biotechnology sectors. The firm’s vision is to leverage its focused expertise to identify and capitalize on growth opportunities within these highly specialized markets, aiming to deliver consistent returns for its discerning clientele.
Silver Arc Private Capital has 8 tracked investments across 5 companies. The latest tracked deal is $39.5M Other Equity in Congruence Therapeutics in March 2026.